Xanomeline

Xanomeline | CAS NO: 174656-58-7, Xanomeline is a muscarinic acetylcholine receptor agonist with a unique profile, primarily targeting M1 and M4 receptor subtypes. It has been investigated for several central nervous system (CNS) conditions, primarily because of its pro-cognitive and antipsychotic potential.

We are the Synchemia Research Chemical specializes in manufacturing and supplying of Xanomeline impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities Use: Treatment of schizophrenia symptoms, particularly positive symptoms (like hallucinations and delusions), as well as negative symptoms and cognitive impairment. Status: Under clinical development; xanomeline-trospium (a combination with the peripheral antagonist trospium to reduce side effects) has shown promise in Phase 3 trials.Buy Reliable and High-Purity Xanomeline Impurities, Delivered by Synchemia Research Chemicals.

Download catalogue

Pharmaceutical Reference Standards

Show:

Xanomeline Impurity 11

CAT No	SRC-X24093
CAS No	2644093-98-9
Mol.F.	C7H5N3OS
Mol.Wt.	179.2 g/mol
INV STATUS	CUSTOM SYNTHESIS

Xanomeline Ethoxy impurity

CAT No	SRC-X24094
CAS No	159059-10-6
Mol.F.	C9H13N3OS
Mol.Wt.	211.3 g/mol
INV STATUS	CUSTOM SYNTHESIS

Xanomeline Alcohol impurity

CAT No	SRC-X24095
CAS No	NA
Mol.F.	C8H11N3OS
Mol.Wt.	197.3 g/mol
INV STATUS	CUSTOM SYNTHESIS

Xanomeline Methoxy impurity

CAT No	SRC-X24096
CAS No	131986-29-3
Mol.F.	C9H13N3OS
Mol.Wt.	211.3 g/mol
INV STATUS	CUSTOM SYNTHESIS

Xanomeline Tartrate

CAT No	SRC-X24097
CAS No	152854-19-8
Mol.F.	C14H23N3OS : C4H6O6
Mol.Wt.	281.4 : 150.1 g/mol
INV STATUS	CUSTOM SYNTHESIS

N-Desmethyl Xanomeline

CAT No	SRC-X24098
CAS No	131986-96-4
Mol.F.	C13H21N3OS
Mol.Wt.	267.4 g/mol
INV STATUS	IN STOCK

Xanomeline Hydrochloride Impurity 8

CAT No	SRC-X24099
CAS No	2413867-73-7
Mol.F.	C7H7N3.2HCl
Mol.Wt.	206.07 g/mol
INV STATUS	IN STOCK

3-(hexyloxy)-4-(1-methyl-1,4,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazole

CAT No	SRC-X24100
CAS No	NA
Mol.F.	C14H23N3OS
Mol.Wt.	281.4 g/mol
INV STATUS	IN STOCK

3-(hexyloxy)-4-(1-methyl-1,2,3,4-tetrahydropyridin-3-yl)-1,2,5-thiadiazole

CAT No	SRC-X24101
CAS No	NA
Mol.F.	C14H23N3OS
Mol.Wt.	281.4 g/mol
INV STATUS	IN STOCK

3-(hexyloxy)-4-(1-methyl-1,2,3,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazole

CAT No	SRC-X24102
CAS No	NA
Mol.F.	C14H23N3OS
Mol.Wt.	281.4 g/mol
INV STATUS	IN STOCK

3-(4-(hexyloxy)-1,2,5-thiadiazol-3-yl)-1-methylpiperidin-3-ol

CAT No	SRC-X24103
CAS No	NA
Mol.F.	C14H25N3O2S
Mol.Wt.	299.1 g/mol
INV STATUS	IN STOCK

3-(4-(hexyloxy)-1,2,5-thiadiazol-3-yl)-1-methylpiperidin-4-ol

CAT No	SRC-X24104
CAS No	NA
Mol.F.	C14H25N3O2S
Mol.Wt.	299.1 g/mol
INV STATUS	IN STOCK

Previous 1 2 3 Next

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.

EXPLORE OUR SERVICES